DRRX - Durect - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Durect's activity chart (see below) currently has 46 price targets and 60 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 20.2% of the time, taking 107.73 days on average.

Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 29-Jul-2025. First documented stock forecast 03-Mar-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Sep-2023

$2.5

1 years 3 months 23 days ago
(29-Jul-2025)

0/2 (0%)

$0.62 (32.98%)

Hold Since 28-Mar-2024

1 years 7 months 25 days ago
(27-Mar-2025)

2/9 (22.22%)

$27.19 (565.28%)

847

Buy Since 22-Jan-2020

$5

$32

2 years 7 months 20 days ago
(01-Apr-2024)

0/7 (0%)

$3.89 (350.45%)

Buy Since 30-Oct-2020

5 years 6 months 16 days ago
(05-May-2021)

0/2 (0%)

$51.3 (178.75%)

Buy Since 06-Sep-2019

$70

$70

5 years 9 months 19 days ago
(02-Feb-2021)

0/3 (0%)

$45.2 (182.26%)

Show more analysts

Please expand the browser size to see the chart

What is DRRX (Durect) average time for price targets to be met?

On average it took 108 days for the stock forecasts to be reached, with an average price target met ratio of 20.2%.

Which analyst most recently updated their price target on DRRX (Durect)?

Carl Byrnes

Which analyst has the most public recommendations on DRRX (Durect)?

Carl Byrnes works at NORTHLAND CAPITAL MARKETS and has 8 price targets and 5 ratings on DRRX

Which analyst is the currently most bullish on DRRX (Durect)?

Elemer Piros with the highest potential upside of $68.09

Which analyst is the currently most reserved on DRRX (Durect)?

Michael Morabito with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?